Savara Inc
Stock Chart, Company Information, and Scan Results
$3.56(as of Sep 12, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Savara Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$3.56
Ticker SymbolSVRA
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees59
CountyUSA
Market Cap$615.3M
EBIDTA-116.5M
P/E Ratio-6.98
Forward P/E Ratio0.00
Earnings per Share-0.51
Profit Margin-Infinity%
RSI63.93
Shares Outstanding172.8M
ATR0.19
52-Week High4.70
Volume2,007,385
52-Week Low1.89
Book Value120.5M
P/B Ratio6.40
Upper Keltner3.80
P/S Ratio2,832.70
Lower Keltner2.94
Next Earnings Date11/06/2025
Cash Surplus3.8M
Next Ex-Dividend DateUnknown
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in 2007 and is headquartered in Langhorne, Pennsylvania.
Savara Inc In Our Stock Scanner
As of Sep 15, 2025
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.